66 related articles for article (PubMed ID: 28868654)
1. A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulation.
Valle M; Di Salle E; Jannuzzo MG; Poggesi I; Rocchetti M; Spinelli R; Verotta D
Br J Clin Pharmacol; 2005 Mar; 59(3):355-64. PubMed ID: 15752382
[TBL] [Abstract][Full Text] [Related]
2. An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer.
Roncato R; Gerratana L; Palmero L; Gagno S; Poetto AS; Peruzzi E; Zanchetta M; Posocco B; De Mattia E; Canil G; Alberti M; Orleni M; Toffoli G; Puglisi F; Cecchin E
Front Pharmacol; 2022; 13():897951. PubMed ID: 35942220
[TBL] [Abstract][Full Text] [Related]
3. Genetic Influences in Breast Cancer Drug Resistance.
Daniyal A; Santoso I; Gunawan NHP; Barliana MI; Abdulah R
Breast Cancer (Dove Med Press); 2021; 13():59-85. PubMed ID: 33603458
[TBL] [Abstract][Full Text] [Related]
4. Genetic Underpinnings of Musculoskeletal Pain During Treatment With Aromatase Inhibitors for Breast Cancer: A Biological Pathway Analysis.
Zhu Y; Koleck TA; Bender CM; Conley YP
Biol Res Nurs; 2020 Apr; 22(2):263-276. PubMed ID: 31847542
[TBL] [Abstract][Full Text] [Related]
5. Effects of
Dempsey JM; Kidwell KM; Gersch CL; Pesch AM; Desta Z; Storniolo AM; Stearns V; Skaar TC; Hayes DF; Henry NL; Rae JM; Hertz DL
Pharmacogenomics; 2019 Jun; 20(8):571-580. PubMed ID: 31190621
[No Abstract] [Full Text] [Related]
6. SLCO1B1 polymorphism and oral antidiabetic drugs.
Kalliokoski A; Neuvonen PJ; Niemi M
Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):775-81. PubMed ID: 20406215
[TBL] [Abstract][Full Text] [Related]
7. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.
Niemi M; Pasanen MK; Neuvonen PJ
Pharmacol Rev; 2011 Mar; 63(1):157-81. PubMed ID: 21245207
[TBL] [Abstract][Full Text] [Related]
8. Impact of the OATP1B1 c.521T>C single nucleotide polymorphism on the pharmacokinetics of exemestane in healthy post-menopausal female volunteers.
Gregory BJ; Chen SM; Murphy MA; Atchley DH; Kamdem LK
J Clin Pharm Ther; 2017 Oct; 42(5):547-553. PubMed ID: 28868654
[TBL] [Abstract][Full Text] [Related]
9. Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men.
Tian L; Liu H; Xie S; Jiang J; Han L; Huang Y; Li Y
Clin Ther; 2011 May; 33(5):655-63. PubMed ID: 21665049
[TBL] [Abstract][Full Text] [Related]
10. Impact of UGT2B17 Gene Deletion on the Pharmacokinetics of 17-Hydroexemestane in Healthy Volunteers.
Chen SM; Atchley DH; Murphy MA; Gurley BJ; Kamdem LK
J Clin Pharmacol; 2016 Jul; 56(7):875-84. PubMed ID: 26608382
[TBL] [Abstract][Full Text] [Related]
11. Effects of single nucleotide polymorphisms and haplotypes of the SLCO1B1 gene on the pharmacokinetic profile of atorvastatin in healthy Macedonian volunteers.
Daka A; Dimovski A; Kapedanovska A; Vavlukis M; Eftimov A; Labachevski N; Jakjovski K; Geshkovska MN; Nebija D; Mladenovska K
Pharmazie; 2015 Jul; 70(7):480-8. PubMed ID: 26373210
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics.
Niemi M; Backman JT; Kajosaari LI; Leathart JB; Neuvonen M; Daly AK; Eichelbaum M; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2005 Jun; 77(6):468-78. PubMed ID: 15961978
[TBL] [Abstract][Full Text] [Related]
13. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.
Pasanen MK; Neuvonen M; Neuvonen PJ; Niemi M
Pharmacogenet Genomics; 2006 Dec; 16(12):873-9. PubMed ID: 17108811
[TBL] [Abstract][Full Text] [Related]
14. Role of OATP transporters in steroid uptake by prostate cancer cells in vivo.
Green SM; Kaipainen A; Bullock K; Zhang A; Lucas JM; Matson C; Banks WA; Mostaghel EA
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):20-27. PubMed ID: 27645128
[TBL] [Abstract][Full Text] [Related]
15. Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer.
Kadakia KC; Snyder CF; Kidwell KM; Seewald NJ; Flockhart DA; Skaar TC; Desta Z; Rae JM; Otte JL; Carpenter JS; Storniolo AM; Hayes DF; Stearns V; Henry NL
Oncologist; 2016 May; 21(5):539-46. PubMed ID: 27009936
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
